LAVA Therapeutics NV (LVTX) — Capital Reinvestment Ratio
LAVA Therapeutics NV (LVTX) has a Capital Reinvestment Ratio of 0.01x as of December 2022, meaning it reinvests 0% of its operating cash flow ($35.73 Million) in capital expenditures ($265.00K). See how leveraged is LAVA Therapeutics NV's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
LAVA Therapeutics NV Capital Reinvestment Ratio (2022–2022)
This chart tracks LAVA Therapeutics NV's Capital Reinvestment Ratio across 1 annual periods. Check LAVA Therapeutics NV investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for LAVA Therapeutics NV (2022–2022)
Year-by-year Capital Reinvestment Ratio for LAVA Therapeutics NV from 2022 to 2022. For live market cap and broader valuation context, see LAVA Therapeutics NV (LVTX) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.15x | $4.04 Million | $587.00K | — |